HIQA’s Strategic Blueprint for Health Care Excellence: Draft Corporate Plan 2025-2027

By João L. Carapinha

October 28, 2024

The HIQA Draft Corporate Plan 2025-2027 outlines the strategic direction and objectives of the Health Information and Quality Authority (HIQA) for the next three years. It serves as a roadmap for HIQA, emphasizing its commitment to promoting high standards in health and social care services across Ireland. Here are the key points from the document:

Foreword and Introduction

This plan marks HIQA’s 20th anniversary and reflects on its journey of continuous improvement, innovation, and collaboration in enhancing health and social care.

Strategic Direction

The HIQA Draft Corporate Plan 2025-2027 is designed to achieve tangible outcomes by 2027. It focuses on evidence-informed decision-making, standard setting, and regulation to ensure the best possible outcomes for health and social care.

Objectives and Priorities

HIQA aims to ensure that health and social care providers consistently deliver excellent standards of care and the best possible outcomes for service users. Key priorities include:
– Promoting safety and quality in health and social care services.
– Enhancing the health and welfare of the public by ensuring care is safe, effective, and respectful of individual rights.
– Responding to emerging challenges and opportunities in the health and social care landscape.

Stakeholder Engagement

HIQA developed the Draft Corporate Plan 2025-2027 through an extensive engagement programme with stakeholders, including patients, service users, policymakers, service providers, advocacy groups, HIQA staff, and the wider public.

Implementation and Monitoring

HIQA‘s Board and Executive Management Team will closely monitor and review the implementation of the Corporate Plan. A performance delivery agreement is in place between HIQA and the Department of Health to ensure alignment with Government priorities and external challenges.

Key Assumptions

The expansion of HIQA’s remit will occur on a gradual basis with sufficient time and additional resources.
– Extra resources will be allocated to support unplanned activities.
– Exchequer funding will adjust in accordance with changes to public sector pay scales and overall operating costs.

Human Rights and Sustainability

HIQA is dedicated to promoting human rights and valuing the needs of the communities it serves. The plan integrates sustainability and the UN Sustainable Development Goals into all relevant activities.

Long-term Outcomes

The plan establishes desired outcomes over the next three years while considering longer-term impacts, providing benchmarks for measuring success. Key outcomes include advancing HIQA’s vision and mission through improved health and social care standards and results.

Overall, the HIQA Draft Corporate Plan 2025-2027 is a comprehensive document that outlines a clear strategic direction, prioritizes stakeholder engagement, and emphasizes the importance of quality, safety, and sustainability in health and social care services.

Reference url

Recent Posts

semaglutide NAION risk
    

Semaglutide NAION Risk: EMA Review Initiated Amid Conflicting Evidence

🔍 Is semaglutide linked to vision loss?

The European Medicines Agency’s PRAC is currently reviewing the potential risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with semaglutide-containing medicines, including popular treatments like Ozempic and Wegovy. With recent studies yielding conflicting evidence, this review is crucial for patient safety and the future of these therapies.

Read the full article to understand the implications and what this could mean for healthcare providers and patients alike!

#SyenzaNews #Pharmaceuticals #HealthcarePolicy

cervical cancer screening
        

Cost-Effective Cervical Cancer Screening Strategies for Women with HIV in KwaZulu-Natal

💡 *Are single-visit cervical cancer screenings the key to better health outcomes in high HIV prevalence areas?*
A recent study from KwaZulu-Natal, South Africa reveals that repeat single-visit cervical cancer screening using HPV DNA testing is not only the most effective but also the most cost-effective approach for women living with HIV. This aligns with WHO recommendations for comprehensive cervical cancer elimination strategies.

Explore the insights and implications of this vital research that could transform cervical cancer prevention in resource-limited settings.

#SyenzaNews #HealthEconomics #oncology #GlobalHealth

EU Health Technology Assessment
          

Advancing EU Health Technology Assessment: Insights from the HAG Meeting

💡 How can the EU Health Technology Assessment reshape healthcare delivery?

The recent meeting of the Heads of HTA Agencies Group heralds a new era with the operationalization of the EU’s Health Technology Assessment Regulation, aiming to streamline processes and enhance collaboration across member states.

This initiative promises to improve data transparency, foster innovative health technologies, and ultimately, drive better patient outcomes.

Curious to learn more about these significant updates and what they mean for the future of health assessments in the EU? Jump into the full article!

#SyenzaNews #HealthTech #HealthEconomics #DigitalTransformation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.